Search Results - "Malachias, Marcus V.B."

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study by Wijkman, Magnus O., Malachias, Marcus V.B., Claggett, Brian L., Cheng, Susan, Matsushita, Kunihiro, Shah, Amil M., Jhund, Pardeep S., Coresh, Josef, Solomon, Scott D., Vardeny, Orly

“…More stringent blood pressure (BP) goals have led to greater prevalence of apparent resistant hypertension (ARH), yet the long‐term prognostic impact of ARH…”
Get full text

Interarm systolic blood pressure difference is associated with left ventricular concentricity and concentric remodeling by Paiva, Annelise M G, Gomes, Maria I C M, Gomes, Alana C M, Gomes, Lucca C M, Ramalho, Saulo R, Feitosa, Audes D M, Malachias, Marcus V B, Brandão, Andréa A, Sposito, Andrei C, Mota-Gomes, Marco A, Nadruz, Jr, Wilson

“…Interarm systolic blood pressure difference (IASD) values >15 mmHg (IASD > 15) are associated with increased cardiovascular risk, yet the underlying mechanisms…”
Get full text

Should arm positioning matter in the diagnosis of orthostatic hypotension and hypertension? by Paiva, Annelise M G, Gomes, Maria I C M, Silva, Érica A A, Feitosa, Audes D M, Malachias, Marcus V B, Sposito, Andrei C, Mota-Gomes, Marco A, Nadruz, Jr, Wilson

Get full text

Importance of NT-proBNP and conventional risk factors for prediction of death in older adults with and without diabetes mellitus- A report from the Atherosclerosis Risk in Communities (ARIC) study by Wijkman, Magnus O, Claggett, Brian L, Malachias, Marcus V B, Vaduganathan, Muthiah, Ballantyne, Christie M, Kitzman, Dalane W, Mosley, Thomas, Matsushita, Kunihiro, Solomon, Scott D, Pfeffer, Marc A

“…In this community-based cohort of 5861 individuals followed for median 7.2 years, the discriminatory ability of NT-proBNP alone in predicting mortality was…”
Get full text

NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus by Malachias, Marcus V B, Jhund, Pardeep S, Claggett, Brian L, Wijkman, Magnus O, Bentley-Lewis, Rhonda, Chaturvedi, Nishi, Desai, Akshay S, Haffner, Steven M, Parving, Hans-Henrik, Prescott, Margaret F, Solomon, Scott D, De Zeeuw, Dick, McMurray, John J V, Pfeffer, Marc A

“…Background NT-proBNP (N-terminal pro-B-type natriuretic peptide) improves the discriminatory ability of risk-prediction models in type 2 diabetes mellitus…”
Get full text

2-OR: Impact of N Terminal Pro B-Type Natriuretic Peptide and High Sensitivity Cardiac Troponin on the Prediction of Death and Cardiovascular Events in High-Risk Patients with Type 2 Diabetes by MALACHIAS, MARCUS V.B., JHUND, PARDEEP, CLAGGETT, BRIAN, WIJKMAN, MAGNUS O., BENTLEY-LEWIS, RHONDA, BRUNEL, PATRICK C., CHATURVEDI, NISHI, DESAI, AKSHAY S., HAFFNER, STEVEN M., PARVING, HANS-HENRIK D., PRESCOTT, MARGARET F., SOLOMON, SCOTT, ZEEUW, DICK DE, MCMURRAY, JOHN J., PFEFFER, MARC A.

“…We assessed the relative contributions of N-terminal pro-B-type natriuretic peptide (NTBNP) and high sensitivity cardiac troponin (hsTnT) to the prediction of…”
Get full text